Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PETER GRAHAM ROSE

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1972530293
CMS profile
271117
Location
CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$11.17

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $11.17 1

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Ethicon US, LLC $11.17 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PETER GRAHAM ROSE

NPI 1972530293 · CMS profile ID 271117

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology / Gynecologic Oncology

CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972530293?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PETER GRAHAM ROSE, NPI 1972530293, CMS profile ID 271117. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972530293?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). PETER GRAHAM ROSE, NPI 1972530293, CMS profile ID 271117. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972530293?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
PETER GRAHAM ROSE, NPI 1972530293, CMS profile ID 271117, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1972530293?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $11.17 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Ethicon US, LLC $11.1707/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 718917213 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $409.23 5
PY2020 $11.17 1
PY2021 $253.76 3
PY2022 $97.13 2
PY2023 $243.38 4
PY2024 $2,619.87 5
PY2025 $120.53 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $59,915.82 36
PY2024 Principal investigator $122,555.68 90
PY2023 Principal investigator $83,530.41 18
PY2022 Principal investigator $185,097.72 27
PY2021 Principal investigator $115,797.72 18
PY2020 Principal investigator $248,307.25 23
PY2019 Principal investigator $509,138.01 42

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

90 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $503.99 12/31/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
";A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy"; No dispute reported 06/30/2026 1155802660
Principal investigator 1 ABBVIE INC. $4,130.00 11/27/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) No dispute reported 06/30/2026 1100685347
Principal investigator 1 ABBVIE INC. $12,727.40 11/25/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) No dispute reported 06/30/2026 1100685345
Principal investigator 1 Iovance Biotherapeutics, Inc. $5,345.60 10/29/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
NCT03108495 No dispute reported 06/30/2026 1146397734
Principal investigator 1 Daiichi Sankyo Inc. $3.90 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059366
Principal investigator 1 Daiichi Sankyo Inc. $3.90 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059368
Principal investigator 1 Daiichi Sankyo Inc. $3.90 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059370
Principal investigator 1 Daiichi Sankyo Inc. $10.52 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059372
Principal investigator 1 Daiichi Sankyo Inc. $10.52 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059374
Principal investigator 1 Daiichi Sankyo Inc. $10.52 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059376
Principal investigator 1 Daiichi Sankyo Inc. $12.12 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059378
Principal investigator 1 Daiichi Sankyo Inc. $12.12 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059380
Principal investigator 1 Daiichi Sankyo Inc. $12.12 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059382
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059384
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059386
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059388
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059390
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059392
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059394
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059396
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059398
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059400
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059402
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059404
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059406
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059408
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059410
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059412
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059414
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059416
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059418
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059420
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059422
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059424
Principal investigator 1 Daiichi Sankyo Inc. $13.53 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059426
Principal investigator 1 Daiichi Sankyo Inc. $13.53 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059428
Principal investigator 1 Daiichi Sankyo Inc. $13.53 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059430
Principal investigator 1 Daiichi Sankyo Inc. $17.70 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059432
Principal investigator 1 Daiichi Sankyo Inc. $17.70 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059434
Principal investigator 1 Daiichi Sankyo Inc. $17.70 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059436
Principal investigator 1 Daiichi Sankyo Inc. $17.70 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059438
Principal investigator 1 Daiichi Sankyo Inc. $17.70 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059440
Principal investigator 1 Daiichi Sankyo Inc. $17.70 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059442
Principal investigator 1 Daiichi Sankyo Inc. $22.71 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059444
Principal investigator 1 Daiichi Sankyo Inc. $22.71 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059446
Principal investigator 1 Daiichi Sankyo Inc. $22.71 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059448
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059450
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059452
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059454
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059456
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059458
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059460
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059462
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059464
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059466
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059468
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059470
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059472
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059474
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059476
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059478
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059480
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059482
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059484
Principal investigator 1 Daiichi Sankyo Inc. $28.75 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059486
Principal investigator 1 Daiichi Sankyo Inc. $28.75 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059488
Principal investigator 1 Daiichi Sankyo Inc. $28.75 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059490
Principal investigator 1 Daiichi Sankyo Inc. $44.50 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059492
Principal investigator 1 Daiichi Sankyo Inc. $44.50 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059494
Principal investigator 1 Daiichi Sankyo Inc. $44.50 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059496
Principal investigator 1 Daiichi Sankyo Inc. $45.61 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059498
Principal investigator 1 Daiichi Sankyo Inc. $45.61 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059500
Principal investigator 1 Daiichi Sankyo Inc. $45.61 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059502
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059504
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059506
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/02/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
DS6000-109 No dispute reported 06/30/2026 1086059508
Principal investigator 1 ABBVIE INC. $1,680.00 09/20/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) No dispute reported 06/30/2026 1100685313
Principal investigator 1 ABBVIE INC. $6,610.80 09/20/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) No dispute reported 06/30/2026 1100685315
Principal investigator 1 Genmab U.S., Inc. $810.00 09/16/2024 Non-covered Recipient Entity
CLEVELAND CLINIC FOUNDATION
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer. No dispute reported 06/30/2026 1125188735
Principal investigator 1 ABBVIE INC. $817.60 05/15/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685233
Principal investigator 1 ABBVIE INC. $35,319.20 05/15/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685235
Principal investigator 1 ABBVIE INC. $21,648.20 05/15/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685237
Principal investigator 1 ABBVIE INC. $6,820.80 05/15/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685239
Principal investigator 1 ABBVIE INC. $4,233.60 05/15/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685241
Principal investigator 1 ABBVIE INC. $2,444.40 04/10/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685225
Principal investigator 1 ABBVIE INC. $2,898.00 04/05/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685215
Principal investigator 1 ABBVIE INC. $2,898.00 04/05/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685217
Principal investigator 1 ABBVIE INC. $2,464.00 04/05/2024 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) No dispute reported 06/30/2026 1100685219
Principal investigator 1 Genmab U.S., Inc. $750.00 04/01/2024 Non-covered Recipient Entity
CLEVELAND CLINIC FOUNDATION
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer. No dispute reported 06/30/2026 1125188730
Principal investigator 1 AstraZeneca Pharmaceuticals LP $8,895.62 03/29/2024 Covered Recipient Teaching Hospital
Cleveland Clinic Hospital
";A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy"; No dispute reported 06/30/2026 1110842367